Increased conviction in Patient Opportunity’s lead manager and supporting cast warrants a People Pillar upgrade to Above Average from Average, while its Process Pillar remains Average.
Patient Opportunity Trust Class C LMOPX
- NAV / 1-Day Return 46.96 / −1.43 %
- Total Assets 2.0B
-
Adj. Expense Ratio
1.970%
- Expense Ratio 2.440%
- Distribution Fee Level Above Average
- Share Class Type Level Load
- Category Mid-Cap Value
- Investment Style Mid Value
- Min. Initial Investment 1,000
- Status Open
- TTM Yield 0.00
- Turnover 27%
USD | NAV as of Jul 18, 2026 | 1-Day Return as of Jul 18, 2026, 1:19 AM GMT+0
Morningstar’s Analysis LMOPX
Will LMOPX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 49.7
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Royalty Pharma PLC Class A | 6.33 | 140M | Healthcare |
Citigroup Inc | 6.32 | 140M | Financial Services |
Alphabet Inc Class A | 6.05 | 134M | Communication Services |
UnitedHealth Group Inc | 5.63 | 125M | Healthcare |
Amazon.com Inc | 5.11 | 113M | Consumer Cyclical |
NVIDIA Corp | 4.52 | 100M | Technology |
CVS Health Corp | 4.09 | 91M | Healthcare |
QXO Inc | 4.06 | 90M | Industrials |
Norwegian Cruise Line Holdings Ltd | 3.81 | 84M | Consumer Cyclical |
Precigen Warrant Restricted | 3.80 | 84M | — |
United States